Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ann Cox"'
Autor:
Brett King, Emma Guttman-Yassky, Elena Peeva, Anindita Banerjee, Linda Zhu, Hua Zhu, Lori Ann Cox, Michael S. Vincent, Rodney Sinclair
Publikováno v:
JID Innovations, Vol 2, Iss 6, Pp 100156- (2022)
The 24-week, double-blind period of the ALLEGRO phase 2a trial (NCT02974868) evaluated the safety and efficacy of ritlecitinib (Jak3/tyrosine kinase expressed in the hepatocellular carcinoma inhibitor) and brepocitinib (tyrosine kinase 2/Jak1 inhibit
Externí odkaz:
https://doaj.org/article/0116e2d715b245428d9d62d101f6f5d4
Autor:
Roché Mahon, Christina Greene, Shelly-Ann Cox, Zack Guido, Andrea K. Gerlak, Jodi-Ann Petrie, Adrian Trotman, Diana Liverman, Cédric J. Van Meerbeeck, Wazita Scott, David Farrell
Publikováno v:
Climate Services, Vol 13, Iss , Pp 14-23 (2019)
Climate services are becoming an important strategy for delivering climate information to users around the world. In many countries, National Meteorological and Hydrological Services (NMHSs) are charged with providing climate services to diverse audi
Externí odkaz:
https://doaj.org/article/3a149245ce3a4d3da34ac48c415f8f34
Autor:
Ann Cox
Publikováno v:
Participation in Children and Young People’s Mental Health ISBN: 9781003288800
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::723b06caf5e1a91439f0286147fdfe03
https://doi.org/10.4324/9781003288800-10
https://doi.org/10.4324/9781003288800-10
Supplementary Data from 3-Phosphoinositide–Dependent Protein Kinase-1 Regulates Proliferation and Survival of Cancer Cells with an Activated Mitogen-Activated Protein Kinase Pathway
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144b149a15569bb22e5cfb1913e41a0e
https://doi.org/10.1158/1541-7786.22519194.v1
https://doi.org/10.1158/1541-7786.22519194.v1
Autor:
Lori Ann Cox, Ana B. Pavel, Weidong Zhang, Ester Del Duca, Martin E. Dowty, Yeriel Estrada, Elena Peeva, Karen Page, Anindita Banerjee, Brett A. King, Linda Zhu, Christopher Banfield, Michael S. Vincent, Aisleen Diaz, Emma Guttman-Yassky, Ning Zhang
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:1318-1328
Background Janus kinase (JAK) inhibitors have shown encouraging results in the treatment of alopecia areata (AA), an autoimmune form of hair loss, in small, uncontrolled studies and case reports. Objective To conduct a biopsy sub-study during the ran
Autor:
Elena Peeva, Yuji Yamaguchi, Brett King, George Han, Lori Ann Cox, Anindita Banerjee, Mauro Picardo, Jung Min Bae, Abigail Sloan, Rodney Sinclair, Khaled Ezzedine
Publikováno v:
British Journal of Dermatology. 188
Ritlecitinib, an oral JAK3/TEC inhibitor, inhibits cytokines IL-15 and IFN-γ that play a critical role in vitiligo pathogenesis. In a phase 2b trial, ritlecitinib demonstrated a significant improvement on the centrally read Facial Vitiligo Area Scor
Autor:
Yuji Yamaguchi, Elena Peeva, Ronald Shore, George Han, Lori Ann Cox, Anindita Banerjee, Diamant Thaci, Iltefat Hamzavi, Abigail Sloan, Anand K Ganesan, Khaled Ezzedine
Publikováno v:
British Journal of Dermatology. 188
Patients with active nonsegmental vitiligo (NSV) may experience active lesions (confetti-like and trichrome lesions) or stable lesions (where lesions may remain unchanged for ∼1 year or more). In a phase 2b trial, the oral JAK3/TEC inhibitor ritlec
Publikováno v:
Creating Resilient Landscapes in an Era of Climate Change ISBN: 9781003266440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e60cf20dc7ab50a004baba9e2177edf2
https://doi.org/10.4324/9781003266440-6
https://doi.org/10.4324/9781003266440-6
Autor:
Karen Page, Emma Guttman-Yassky, Christopher Banfield, Linda H. Chen, Lori Ann Cox, Brett A. King, Weidong Zhang, Brittany G. Craiglow, Rodney Sinclair, Anindita Banerjee, Michael S. Vincent, Ana B. Pavel, Linda Zhu, Elena Peeva
Publikováno v:
Journal of the American Academy of Dermatology. 85:379-387
Background Alopecia areata (AA) is an autoimmune form of hair loss with limited treatments. Objective To evaluate the efficacy and safety of the Janus kinase inhibitors ritlecitinib and brepocitinib in patients who have AA with ≥ 50% scalp hair los